HLA-Associated immune pressure on gag protein in CRF01_AE-Infected individuals and its association with plasma viral load

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Gesprasert, Goragoch ^a   Wichukchinda, Nuanjun ^b   Mori, Masahiko ^c   Shiino, Teiichiro ^d   Auwanit, Wattana ^b   Sriwanthana, Busarawan ^b   Pathipvanich, Panita ^e   Sawanpanyalert, Pathom ^b   Miura, Toshiyuki ^f   Auewarakul, Prasert ^g   Thitithanyanont, Arunee ^a   Ariyoshi, Koya ^c  

^a Mahidol University ^*  (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c NAGASAKI UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e LAMPANG HOSPITAL   (Thailand)

^f UNIVERSITY OF TOKYO   (Japan)

^g MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAPSID PROTEIN; GAG PROTEIN; HLA ANTIGEN; PRIMER DNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CYTOTOXIC T LYMPHOCYTE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVERTANT; SEQUENCE ANALYSIS; THAILAND; UNINDEXED SEQUENCE; VIRUS LOAD; ALLELE; DISEASE TRANSMISSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MUTATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

ALLELES; BASE SEQUENCE; DNA PRIMERS; GENE PRODUCTS, GAG; HIV INFECTIONS; HLA ANTIGENS; MUTATION; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 77956202588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011179     Document Type: Article

References (35)

1. Goulder PJ, Watkins DI (2004) HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4: 630-640.
2. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, et al. (2004) HIV vaccine design and the neutralizing antibody problem. Nat Immunol 5: 233-236.
3. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
4. McMichael AJ, Hanke T (2003) HIV vaccines 1983-2003. Nat Med 9: 874-880.
5. Sekaly RP (2008) The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J Exp Med 205: 7-12.
6. Buonaguro L, Tornesello ML, Buonaguro FM (2007) Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol 81: 10209-10219.
7. Stephens HA (2005) HIV-1 diversity versus HLA class I polymorphism. Trends Immunol 26: 41-47.
8. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, et al. (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3: 205-211.
9. Furutsuki T, Hosoya N, Kawana-Tachikawa A, Tomizawa M, Odawara T, et al. (2004) Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population. J Virol 78: 8437-8445.
10. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, et al. (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3: 212-217.
11. Moore CB, John M, James IR, Christiansen FT, Witt CS, et al. (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439-1443.
12. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, et al. (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
13. Brumme ZL, Brumme CJ, Carlson J, Streeck H, John M, et al. (2008) Marked epitope and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 82: 9216-9227.
14. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, et al. (2007) Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 3: e94.
15. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, et al. (2009) HLAassociated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4: e6687.
16. Ruxrungtham K, Brown T, Phanuphak P (2004) HIV/AIDS in Asia. Lancet 364: 69-82.
17. Lau KA, Wang B, Saksena NK (2007) Emerging trends of HIV epidemiology in Asia. AIDS Rev 9: 218-229.
18. Wichukchinda N, Kitamura Y, Rojanawiwat A, Nakayama EE, Song H, et al. (2007) The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses 23: 686-692.
19. Kumar S, Tamura K, Nei M (2004) MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5: 150-163.
20. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, et al. (2006) Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol 2: e62.
21. Pond SL, Frost SD, Muse SV (2005) HyPhy: hypothesis testing using phylogenies. Bioinformatics 21: 676-679.
22. Fongsatikul L, Nantachit N, Kamtorn N, Leetrakool N (1997) HLA gene frequencies of northern Thais. J Med Assoc Thai 80 Suppl 1: S38-42.
23. Romphruk A, Burusrux S, Puapairoj C, Urwijitaroon Y, Leelayuwat C (1996) Distribution of HLA-A and B antigens in northeastern-Thais. J Med Assoc Thai 79: 732-736.
24. Nicole Frahm BB, Christian Brander (2008) Identification and optimal definition of HIV-derived cytotoxic T lymphocyte (CTL) epitopes for the study of CTL escape, functional avidity and viral evolution. In: Bette TM, Korber CB, Barton FHaynes, RichardKoup, John PMoore, Bruce DWalker, David IWatkins, eds. HIV Molecular Immunology 2008. Los Alamos, New Mexico: Los Alamos National Laboratory, Theoretical Biology and Biophysics. pp 3-24.
25. Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, et al. (2007) Escape and compensation from early HLA-B57-mediated cytotoxic Tlymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol 81: 12608-12618.
26. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, et al. (2006) Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 80: 3617-3623.
27. Goulder PJ, Bunce M, Krausa P, McIntyre K, Crowley S, et al. (1996) Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses 12: 1691-1698.
28. Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, et al. (2008) Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog 4: e1000033.
29. Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, et al. (2008) Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205: 1009-1017.
30. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, et al. (2007) Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 81: 12382-12393.
31. Zuniga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, et al. (2006) Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 80: 3122-3125.
32. Altfeld M, Kalife ET, Qi Y, Streeck H, Lichterfeld M, et al. (2006) HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med 3: e403.
33. Matthews PC, Leslie AJ, Katzourakis A, Crawford H, Payne R, et al. (2009) HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering. J Virol 83: 4605-4615.
34. Geldmacher C, Currier JR, Herrmann E, Haule A, Kuta E, et al. (2007) CD8 Tcell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol 81: 2440-2448.
35. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al. (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10: 282-289.